Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2026 Earnings Call Transcript
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2026 Earnings Call Transcript May 6, 2026Tarsus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.40033.



